Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice

被引:20
|
作者
Shimazu-Kuwahara, Satoko [1 ]
Harada, Norio [1 ]
Yamane, Shunsuke [1 ]
Joo, Erina [1 ]
Sankoda, Akiko [1 ]
Kieffer, Timothy J. [2 ]
Inagaki, Nobuya [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan
[2] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada
来源
MOLECULAR METABOLISM | 2017年 / 6卷 / 03期
关键词
GIP; Hyperphagia; Obesity; Insulin resistance; ob/ob; GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2; DIABETES-MELLITUS; ENTEROENDOCRINE K CELLS; DIET-INDUCED OBESITY; HIGH-FAT DIET; BYPASS-SURGERY; INCRETIN LEVELS; LEPTIN; STIMULATION; INTOLERANCE;
D O I
10.1016/j.molmet.2017.01.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Glucose-dependent insulinotropic polypeptide (GIP) is released during meals and promotes nutrient uptake and storage. GIP receptor knockout mice are protected from diet induced weight gain and thus GIP antagonists have been proposed as a treatment for obesity. In this study, we assessed the role of GIP in hyperphagia induced obesity and metabolic abnormalities in leptin deficient (Lep(ob/ob)) mice. Methods: We crossbred GIP-GFP knock-in homozygous mice (GIPgfp/gfp) that have complete GIP knockout, and mice heterozygous for the ob mutation ( Lep(ob/+))mice to generate Lep(ob)/(+)/GIP(+/ +), Lep(ob/ob)/GIP(+/+), and Lep(ob/ob)/GIP(gfp/gfp) mice. Male animals were weighed weekly and both oral glucose and insulin tolerance testing were performed to assess glucose homeostasis and circulating profiles of GIP and insulin. Body composition was evaluated by computerized tomography ( CT) scan and analyses of indirect calorimetry and locomotor activity were performed. Results: Postprandial GIP levels were markedly elevated in Lep(ob/ob)/GIP(+/+) mice compared to Lep(ob/ob)/GIP(+/+) controls and were undetectable in Lep(ob/ob)/GIP(gfp/gfp) mice. Insulin levels were equivalently elevated in both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice compared to controls at 8 weeks of age but the hyperinsulinemia was marginally reduced in Lep(ob/ob)/GIP(gfp/gfp) by 21 weeks, in association with amelioration of glucose intolerance. Both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice remained equivalently insulin resistant. Body weight gain and subcutaneous and visceral fat volume of both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice were significantly higher than that of Lep(ob/+)/GIP(+/+) mice, while no significant differences were seen between Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice. Locomotor activity and energy expenditure were decreased in both Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice compared to control Lep(ob/+)/ GIP(+/+) mice, while no significant differences were seen between Lep(ob/ob)/GIP(+/+) and Lep(ob/ob)/GIP(gfp/gfp) mice. There was no significant difference in fat oxidation among the three groups. Fat content in liver was significantly lower in Lep(ob/ob)/GIP(gfp/gfp) compared to Lep(ob/ob)/GIP(+/+) mice, while that of control Lep(ob/+)/GIP(+/ +) mice was the lowest. Conclusions: Our results indicate that GIP knockout does not prevent excess weight gain and metabolic derangement in hyperphagic leptin deficient mice. (C) 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
引用
下载
收藏
页码:288 / 294
页数:7
相关论文
共 50 条
  • [11] Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP) - Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat
    Tseng, CC
    Kieffer, TJ
    Jarboe, LA
    Usdin, TB
    Wolfe, MM
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11): : 2440 - 2445
  • [12] Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
    Heimburger, Sebastian M.
    Bergmann, Natasha C.
    Augustin, Robert
    Gasbjerg, Laerke S.
    Christensen, Mikkel B.
    Knop, Filip K.
    PEPTIDES, 2020, 125
  • [13] Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats
    Irwin, Nigel
    Francis, Jacqueline M. E.
    Flatt, Peter R.
    BIOLOGICAL CHEMISTRY, 2011, 392 (10) : 909 - 918
  • [14] Glucose-dependent insulinotropic polypeptide (GIP) deficiency improves obesity but worsens bone loss in ovariectomised mice
    Kanemaru, Y.
    Harada, N.
    Simazu-Kuwahara, S.
    Ueda, Y.
    Yamane, S.
    Murata, Y.
    Kieffer, T. J.
    Inagaki, N.
    DIABETOLOGIA, 2017, 60 : S228 - S229
  • [15] Glucose-Dependent Insulinotropic Polypeptide A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
    Christensen, Mikkel
    Vedtofte, Louise
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES, 2011, 60 (12) : 3103 - 3109
  • [16] Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in man
    Christensen, M.
    Vedtofte, L.
    Vilsboll, T.
    Holst, J. J.
    Knop, F. K.
    DIABETOLOGIA, 2011, 54 : S60 - S60
  • [17] Glucose-dependent insulinotropic polypeptide monoclonal antibodies prevent and treat obesity in wild-type and hyperphagic mice
    Wolfe, M. Michael
    Apovian, Caroline M. M.
    Boylan, Michael O. O.
    OBESITY, 2023, 31 (06) : 1499 - 1504
  • [18] Phylogeny of Glucose-Dependent Insulinotropic Polypeptide (GIP) Expression: Implications for Nutrient Efficiency and Obesity
    Musson, Michelle
    Jepeal, Lisa I.
    Mabray, Patrick D.
    Kavanaugh, Scott I.
    Zhdanova, Irina V.
    Sower, Stacia A.
    Wolfe, M. Michael
    GASTROENTEROLOGY, 2009, 136 (05) : A731 - A732
  • [19] Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulates Transepithelial Glucose Transport
    Singh, Satish K.
    Bartoo, Aaron C.
    Krishnan, Selvi
    Boylan, Michael O.
    Schwartz, John H.
    Wolfe, M. Michael
    OBESITY, 2008, 16 (11) : 2412 - 2416
  • [20] A RADIOIMMUNOASSAY (RIA) FOR HUMAN GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)
    SAITO, T
    SCHWARTZ, K
    CLINICAL CHEMISTRY, 1987, 33 (06) : 893 - 893